Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Catherine L. Kwik-Uribe is active.

Publication


Featured researches published by Catherine L. Kwik-Uribe.


The American Journal of Clinical Nutrition | 2011

Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study

Xenofon Tzounis; Ana Rodriguez-Mateos; Jelena Vulevic; Glenn R. Gibson; Catherine L. Kwik-Uribe; Jeremy P. E. Spencer

BACKGROUND The absorption of cocoa flavanols in the small intestine is limited, and the majority of the flavanols reach the large intestine where they may be metabolized by resident microbiota. OBJECTIVE We assessed the prebiotic potential of cocoa flavanols in a randomized, double-blind, crossover, controlled intervention study. DESIGN Twenty-two healthy human volunteers were randomly assigned to either a high-cocoa flavanol (HCF) group (494 mg cocoa flavanols/d) or a low-cocoa flavanol (LCF) group (23 mg cocoa flavanols/d) for 4 wk. This was followed by a 4-wk washout period before volunteers crossed to the alternant arm. Fecal samples were recovered before and after each intervention, and bacterial numbers were measured by fluorescence in situ hybridization. A number of other biochemical and physiologic markers were measured. RESULTS Compared with the consumption of the LCF drink, the daily consumption of the HCF drink for 4 wk significantly increased the bifidobacterial (P < 0.01) and lactobacilli (P < 0.001) populations but significantly decreased clostridia counts (P < 0.001). These microbial changes were paralleled by significant reductions in plasma triacylglycerol (P < 0.05) and C-reactive protein (P < 0.05) concentrations. Furthermore, changes in C-reactive protein concentrations were linked to changes in lactobacilli counts (P < 0.05, R(2) = -0.33 for the model). These in vivo changes were closely paralleled by cocoa flavanol-induced bacterial changes in mixed-batch culture experiments. CONCLUSION This study shows, for the first time to our knowledge, that consumption of cocoa flavanols can significantly affect the growth of select gut microflora in humans, which suggests the potential prebiotic benefits associated with the dietary inclusion of flavanol-rich foods. This trial was registered at clinicaltrials.gov as NCT01091922.


Journal of Chromatography A | 2009

Method performance and multi-laboratory assessment of a normal phase high pressure liquid chromatography-fluorescence detection method for the quantitation of flavanols and procyanidins in cocoa and chocolate containing samples

Rebecca J. Robbins; Jadwiga Leonczak; J. Christopher Johnson; Julia Li; Catherine L. Kwik-Uribe; Ronald L. Prior; Liwei Gu

The quantitative parameters and method performance for a normal-phase HPLC separation of flavanols and procyanidins in chocolate and cocoa-containing food products were optimized and assessed. Single laboratory method performance was examined over three months using three separate secondary standards. RSD(r) ranged from 1.9%, 4.5% to 9.0% for cocoa powder, liquor and chocolate samples containing 74.39, 15.47 and 1.87 mg/g flavanols and procyanidins, respectively. Accuracy was determined by comparison to the NIST Standard Reference Material 2384. Inter-lab assessment indicated that variability was quite low for seven different cocoa-containing samples, with a RSD(R) of less than 10% for the range of samples analyzed.


British Journal of Nutrition | 2008

Flavanol monomer-induced changes to the human faecal microflora

Xenofon Tzounis; Jelena Vulevic; Gunter Georg Kuhnle; Trevor George; Jadwiga Leonczak; Glenn R. Gibson; Catherine L. Kwik-Uribe; Jeremy P. E. Spencer


British Journal of Nutrition | 2012

Influence of sugar type on the bioavailability of cocoa flavanols

Ana Rodriguez-Mateos; Maria Jose Oruna-Concha; Catherine L. Kwik-Uribe; Alberto Vidal; Jeremy P. E. Spencer


Archive | 2006

Thermally-processed cocoa products useful for vascular health improvement

Harold H. Schmitz; Catherine L. Kwik-Uribe; John F. Hammerstone; Mark A. Kelm; Rebecca J. Robbins


Archive | 2006

Compositions and methods of use of derivatized flavanols

Catherine L. Kwik-Uribe; Harold H. Schmitz; Mark A. Kelm; Jr. John F. Hammerstone


Archive | 2006

A-type procyanidins and inflammation

Harold H. Schmitz; Catherine L. Kwik-Uribe


Archive | 2006

Treatment of occlusive thrombosis

Harold H. Schmitz; Catherine L. Kwik-Uribe; Paul Jones


Archive | 2007

Mixed 4→6 procyanidin dimers and their use

Harold H. Schmitz; Rebecca J. Robbins; Catherine L. Kwik-Uribe


Archive | 2006

Inducing peripheral blood vessel vasodilation

Catherine L. Kwik-Uribe; Harold H. Schmitz; Mark A. Kelm; John F. Hammerstone

Collaboration


Dive into the Catherine L. Kwik-Uribe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark A. Kelm

Michigan State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rebecca J. Robbins

United States Department of Agriculture

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge